How a proposed tax penalty on drugs with price increases exceeding the inflation could impact patients, public insurance programs, and innovation.
Researchers found nearly a third of approvals from 2001 through 2010 had major safety issues years after they were widely available to patients.
From a $1.2M gene therapy to a $450K lymphoma med, these are the 10 priciest medications out there.
Scientists invented chemical weapons; some are now working to destroy them.
Using surrogate endpoints can speed up testing of new drugs, but doesn’t always find out if they actually help patients.
The three plaintiffs are seeking damages from Mylan to represent a nationwide class of EpiPen purchasers.
How can one possibly deny a dying patient even the slightest chance of prolonged life or recovery? Is there a side effect worse than certain death?